Annual Drug Patent Expirations for APONVIE
Aponvie is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
This drug has nine patent family members in five countries.
The generic ingredient in APONVIE is aprepitant. One supplier is listed for this compound. Additional details are available on the aprepitant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com